Diagnostic Auditory Tests for Hearing Loss in Cochlear Implantees
Trial Summary
What is the purpose of this trial?
This trial studies older adults using cochlear implants to understand why some benefit more than others. It looks at how aging and the health of hearing pathways affect their ability to process sounds. The goal is to improve guidance and outcomes for older adults using these devices.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Diagnostic tests of auditory function and cochlear implant function for hearing loss in cochlear implantees?
Research shows that comprehensive auditory tests, like the Basic Auditory Skills Evaluation Battery, can effectively assess different aspects of hearing in cochlear implant users, providing valuable information about their auditory skills. This suggests that diagnostic tests can help evaluate and improve the function of cochlear implants in patients.12345
Is it safe to undergo diagnostic auditory tests for hearing loss in cochlear implantees?
The research indicates that diagnostic auditory tests, including objective measures like auditory brainstem responses (ABR) and electrocochleography, are reliable and commonly used in both preoperative and postoperative evaluations for cochlear implantees, suggesting they are generally safe for humans.36789
How does the treatment for hearing loss in cochlear implantees differ from other treatments?
This treatment is unique because it focuses on diagnostic auditory tests specifically designed for cochlear implantees, assessing various aspects of auditory perception such as speech perception, music processing, and environmental sound recognition, which are not typically covered in standard clinical testing.2691011
Research Team
Matthew J. Goupell, PhD
Principal Investigator
University of Maryland, College Park
Samira B. Anderson, PhD
Principal Investigator
University of Maryland, College Park
Sandra Gordon-Salant, PhD
Principal Investigator
University of Maryland, College Park
Eligibility Criteria
This trial is for older adults with post-lingual deafness who have been using a Cochlear-brand cochlear implant for over a year. Candidates should have normal to moderate hearing loss and must not be pregnant, use non-Cochlear implants, or have severe hearing loss or neurological disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Collection of baseline data including cognitive screening, history of CI device use, and imaging-based information regarding electrode placement
Treatment
Participants undergo various auditory and speech perception tests to assess temporal processing and speech perception
Follow-up
Participants are monitored for changes in auditory and speech perception after treatment
Treatment Details
Interventions
- Diagnostic tests of auditory function
- Diagnostic tests of cochlear implant function
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, College Park
Lead Sponsor
Vanderbilt University
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator